Learning Objectives:
Head and Neck
1. Understand the role of pembrolizumab in first line treatment of advanced head & neck cancer patients with metastatic or unresectable disease.
2. Consider the options of surgical vs. radiation-based approaches to treatment of HPV-related oropharyngeal cancer.
Thoracic:
1. Learn about immune therapy in lung cancer.
2. Discuss side effects of immune therapy in lung cancer.
3. Review options for other therapies in lung cancer.
Session date:
08/29/2019 - 8:00am to 9:15am CDT
Location:
Evanston Hospital, Room G870
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Bruce Brockstein, M.D. & Nick Campbell, M.D.